Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC)

Clinical trial NCT04243278 · TERMINATED

Trial details

NCT number: NCT04243278
Sponsor: Dr. Graeme Smith
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Preeclampsia Severe Cardiovascular Diseases Primary Prevention

Start date: 2020-09-14
Primary completion: 2022-12-31
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.